News

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Test your knowledge of key words and terms associated with dermatology news from the last month.

Nemvaleukin alfa produced a disease control rate of 50% in advanced melanoma and RCC.

Explore the latest breakthroughs in treatment and research during Hair Loss Awareness Month, enhancing understanding and patient care for hair loss disorders.

Katrina Lee, MD, discussed innovative strategies and challenges in managing HS at the Dermatology Innovation Symposium, emphasizing early intervention and comprehensive care.

Discover how bond-building hair care treatments enhance hair strength and resilience, utilizing innovative technologies for healthier, more vibrant locks.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Research highlights that educational videos on standardized clinical photography protocols significantly lead to better management and treatment outcomes for patients with alopecia.

Renata Block, DMSc, MMS, PA-C, and Isabelle Thibau, MPH, of the National Eczema Association discuss how the EczemaWise app integrates patient-reported outcomes, validated tools, and real-world data to improve collaboration between patients and clinicians in managing eczema.

Advances in biologics and systemics have reshaped the lives of patients with psoriasis, offering clearer skin and joint protection.

Dermatology Times is recapping our exclusive expert interviews from the month of August.

Discover the latest in regenerative aesthetics and body contouring at DERM 2025, featuring insights from Suneel Chilukuri, MD, on skin care trends and biohacking.

Explore essential long-term care insurance options for dermatologists, ensuring financial security and peace of mind for future healthcare needs.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

GLP-1 receptor agonists may indirectly affect dermatologic outcomes by targeting inflammation and metabolic comorbidities.

Members of Elevate-Derm Alliance and the SkinSync podcast discuss the inspiration behind the podcast and how it best serves dermatology clinicians.

Lisa Swanson, MD, FAAD, shares innovative insights on pediatric dermatology, emphasizing effective treatments and communication strategies for young patients at DERM 2025.

Learn more about the in-depth topics covered in the August 2025 print issue of Dermatology Times.

Key regulatory milestones for MAL-838, a novel sCD83-based, hormone-free hair growth ingredient, are paving the way for the market launch of a microbiome-friendly 8T3 product line.

Explore innovative biologic treatments for prurigo nodularis, enhancing patient quality of life and breaking the itch-scratch cycle effectively.

This review of the latest dermatologic studies focuses on chronic spontaneous urticaria with new research on the transition from omalizumab to dupilumab, metabolic syndrome in urticaria patients, current pediatric CSU guidelines, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Case reports showed encouraging outcomes in eczema, but the company is pursuing deeper validation.

Andrew Baker, MBA, MPAS, PA-C, discusses new data highlighting both the growing challenges—like burnout and reimbursement cuts—and exciting opportunities in leadership, virtual care, and mentorship for PAs and NPs.

Explore the top headlines of the month, including insights on regulatory updates, expert pearls, and more.

Discover how biologic coordinators streamline dermatologic care through detailed protocols, clinical documentation, and patient advocacy to improve access to life-changing biologic therapies.

From remote villages to island nations, a WHA resolution and grassroots efforts aim to bridge care gaps in regions lacking access to dermatology providers.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Roundtable participants agreed the art of psoriasis management lies in aligning biologic or oral options with patient comorbidities, lifestyle, and insurance coverage.